ONO-7746 Study in Healthy Adult Subjects

Completed · Phase 1

Conditions studied: Healthy Adult Subjects

In brief

The primary objective of this study is to evaluate the safety and tolerability of ONO-7746 in healthy adult subjects. The secondary objectives are to characterize the pharmacokinetic and pharmacodynamic profiles of ONO-7746.

Key facts

Study ID

NCT00956371

Run by

Ono Pharmaceutical Co., Ltd.

People needed

48

Starts

2009-08-01

Last updated by the study team

2012-06-14

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy non-smoking male or female subjects (18-55 years inclusive)
• Body mass index (BMI) of 19-35 kg/m² (inclusive)
• For females: postmenopausal, non-lactating and non-pregnant

You may not qualify if…

• History or presence of clinically significant disease

Where it is running

• Austin — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.